LSV Asset Management Boosts Stake in InMode Ltd. (NASDAQ:INMD)

LSV Asset Management boosted its holdings in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 15.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,940,071 shares of the healthcare company's stock after buying an additional 261,252 shares during the period. LSV Asset Management owned approximately 2.34% of InMode worth $43,147,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Exchange Traded Concepts LLC purchased a new stake in InMode during the third quarter valued at about $27,000. Carmel Capital Partners LLC purchased a new stake in InMode during the third quarter valued at about $36,000. Sunbelt Securities Inc. purchased a new position in shares of InMode in the third quarter worth about $47,000. CWM LLC increased its holdings in shares of InMode by 38.3% in the fourth quarter. CWM LLC now owns 2,454 shares of the healthcare company's stock worth $55,000 after buying an additional 680 shares during the period. Finally, NBC Securities Inc. purchased a new position in shares of InMode in the third quarter worth about $79,000. Institutional investors own 68.04% of the company's stock.

InMode Price Performance

NASDAQ:INMD traded up $1.01 during mid-day trading on Monday, reaching $18.65. 1,554,418 shares of the company's stock traded hands, compared to its average volume of 1,567,817. InMode Ltd. has a 12-month low of $16.72 and a 12-month high of $48.25. The firm has a market capitalization of $1.57 billion, a price-to-earnings ratio of 8.84 and a beta of 2.20. The company has a 50 day moving average price of $19.86 and a 200-day moving average price of $21.34.

InMode (NASDAQ:INMD - Get Free Report) last announced its quarterly earnings results on Tuesday, February 13th. The healthcare company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. InMode had a return on equity of 26.15% and a net margin of 38.84%. The company had revenue of $126.80 million for the quarter, compared to the consensus estimate of $124.77 million. During the same quarter in the previous year, the business earned $0.69 EPS. InMode's revenue was down 5.1% compared to the same quarter last year. As a group, analysts forecast that InMode Ltd. will post 2.04 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Needham & Company LLC reiterated a "hold" rating on shares of InMode in a report on Friday. UBS Group lifted their price objective on InMode from $24.00 to $26.00 and gave the stock a "neutral" rating in a report on Wednesday, February 14th. Finally, Barclays decreased their price objective on InMode from $34.00 to $33.00 and set an "overweight" rating on the stock in a report on Friday, April 12th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $32.80.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.